Bret Scholtes

Bret Scholtes is a declared insider at 2 companies (chief executive); the most frequent names are Omega Protein Corp and Guardion Health Sciences, Inc. The record holds 24 filings, for trades running from 23 November 2011 to 6 January 2022.

The open-market record is one-sided, with 4 purchases worth €37k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 19 share grants.

The median purchase comes to €7,977.

On 16 June 2022 came the latest disclosure, a share grant for €21k in Guardion Health Sciences, Inc. The last purchase on record was published on 1 September 2021, which is 1,879 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.